Paul Jellinger from the University of Miami: ADA Provides New Insights Into Diabetes Treatment Methods
The annual meeting of the American Diabetes Association provided many studies looking at the condition from a variety of angles. What doctors did with those results when they went back to their practices was up to them.
%jwplayer%
The annual meeting of the American Diabetes Association provided many studies looking at the condition from a variety of angles. What doctors did with those results when they went back to their practices was up to them.
For Paul S. Jellinger, MD, from the University of Miami there were several key studies which caught his attention. One study in particular which he discussed at the conference involved the usage of once weekly exenatide. While not a new medication Jellinger said the study was important because it showed its benefits in helping to control a patient's blood glucose level over an extended period of time.
